Canaccord Genuity Maintains Buy on Hinge Health, Lowers Price Target to $53

Hinge Health, Inc. Class A -0.72%

Hinge Health, Inc. Class A

HNGE

45.51

-0.72%

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE: HNGE) with a Buy and lowers the price target from $65 to $53.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via